Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00526903 · ClinicalTrials.gov registry record · Phase 2

Recurrent Abdominal Pain in Children

A Phase 2 study, sponsored by Baylor College of Medicine.

Completed
Registry status
Phase 2
Development phase
168
Enrollment target

NCT00526903 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 168 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00526903, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
Phase 2
Development phase
168 participants
Enrollment target

Study Summary

The purpose of this study is to: 1. To determine if fiber versus placebo improves symptoms in children with recurrent abdominal pain/irritable bowel syndrome. 2. To determine possible ways fiber or placebo improve(s) symptoms in children with recurrent abdominal pain/irritable bowel syndrome by carrying out gastrointestinal tests and questionnaires. Understanding how diet and fiber affect GI function potentially will benefit the large numbers of children with irritable bowel syndrome (IBS) and provide insight into prevention of IBS in at risk children. We expect that the results from these studies can be used to lessen significantly the huge financial burden to society caused by these chronic conditions. Consent will be obtained from the parent/guardian and assent from the child.

Interventions

  • BEHAVIORAL Elimination Diet

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2009-01
Est. Completion 2014-03
Phase Phase 2

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT00526903

The ClinicalTrials.gov registry entry for NCT00526903 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Elimination Diet is the first listed.

NCT00526903 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00526903 about?

NCT00526903 is a clinical study titled "Recurrent Abdominal Pain in Children". The purpose of this study is to: 1. To determine if fiber versus placebo improves symptoms in children with recurrent abdominal pain/irritable bowel syndrome. 2. To determine possible ways fiber or placebo improve(s) symptoms in children with recurrent abdominal pain/irritable bowel syndrome by car...

What is the current status of trial NCT00526903?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2009-01. Estimated completion is 2014-03.

What interventions are being tested in trial NCT00526903?

The interventions under investigation include: Elimination Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00526903?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.